Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03092063 · ClinicalTrials.gov registry record · NA
Using Multifamily Groups to Improve Self-Management of Type 2 Diabetes
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 330
- Enrollment target
NCT03092063 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 330 participants.
The verdict
NCT03092063, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 330 participants
- Enrollment target
Study Summary
The overall objective of this study is to construct an adaptive intervention that integrates family members and patients as partners in care while promoting diabetes self-management for Mexican Americans with Type 2 diabetes. The project incorporates four evidence-based, culturally tailored treatments using a Sequential, Multiple Assignment Randomized Trial to help determine what sequence of intervention strategies work most efficiently and for whom.
Interventions
- BEHAVIORAL Tomando Control-Nurse
- BEHAVIORAL Tomando Control-Promotora
- BEHAVIORAL Enhanced engagement
- BEHAVIORAL Multifamily Group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 330 participants |
| Start Date | 2017-03-01 |
| Est. Completion | 2021-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03092063
The ClinicalTrials.gov registry entry for NCT03092063 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 330 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Tomando Control-Nurse is the first listed.
NCT03092063 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03092063 about?
NCT03092063 is a clinical study titled "Using Multifamily Groups to Improve Self-Management of Type 2 Diabetes". The overall objective of this study is to construct an adaptive intervention that integrates family members and patients as partners in care while promoting diabetes self-management for Mexican Americans with Type 2 diabetes. The project incorporates four evidence-based, culturally tailored treatmen...
What is the current status of trial NCT03092063?
This trial is currently completed. It is a NA study. The enrollment target is 330 participants. The study started on 2017-03-01. Estimated completion is 2021-07-31.
What interventions are being tested in trial NCT03092063?
The interventions under investigation include: Tomando Control-Nurse (BEHAVIORAL), Tomando Control-Promotora (BEHAVIORAL), Enhanced engagement (BEHAVIORAL), Multifamily Group (BEHAVIORAL).
Who is sponsoring clinical trial NCT03092063?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.